Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Germany
(1,654/week)
France
(1,103/week)
Poland
(1,041/week)
Spain
(800/week)
Czechia
(418/week)
View all
(8,609/week)
News
United States
(455/week)
Manufacturing
(322/week)
Technology
(353/week)
Energy
(216/week)
Other Manufacturing
(273/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Vaccibody
Aug 12, 2020
Vaccibody AS and Nektar Therapeutics Announce First Patient Dosed in a Phase 1/2a Study Arm Evaluating VB10.NEO, a Personalized Neoantigen Cancer Vaccine, with Bempegaldesleukin (NKTR-214) in Patients with Squamous Cell Carcinoma of the Head and Neck
Latest News
Jun 9, 2023
Distribution Solutions Group Completes Hisco Acquisition
Jun 9, 2023
University of Phoenix and Military Police Regimental Association Announce Winner of Full-Tuition Scholarship
Jun 9, 2023
TerraStor Announces Fred E. Reed, Jr. as Chief Commercial Officer
Jun 9, 2023
Pennsylvania American Water Signs Agreement to Purchase Farmington Township’s Water and Wastewater Systems
Jun 9, 2023
Green Plains to Host Inflation Reduction Act Teach-In
Jun 9, 2023
Conditionally Automated Driving: Mercedes-Benz DRIVE PILOT Further Expands U.S. Availability to the Country’s...
Jun 9, 2023
inTEST Announces Completion of $20 Million At-The-Market Offering
Jun 9, 2023
Fortune Brands Innovations Publishes 2022 ESG Report
View all News
